Towa Pharmaceutical Co., Ltd. (TYO:4553)
4,150.00
+160.00 (4.01%)
Mar 5, 2026, 3:30 PM JST
44.05% (1Y)
| Market Cap | 196.42B +38.1% |
| Revenue (ttm) | 269.92B +6.5% |
| Net Income | 21.44B +11.2% |
| EPS | 435.61 +11.2% |
| Shares Out | 49.23M |
| PE Ratio | 9.16 |
| Forward PE | 9.74 |
| Dividend | 80.00 (1.89%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 202,500 |
| Average Volume | 124,140 |
| Open | 4,060.00 |
| Previous Close | 3,990.00 |
| Day's Range | 4,055.00 - 4,185.00 |
| 52-Week Range | 2,298.00 - 4,445.00 |
| Beta | -0.30 |
| RSI | 53.87 |
| Earnings Date | Feb 13, 2026 |